Found: 5
Select item for more details and to access through your institution.
Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1157596
- By:
- Publication type:
- Article
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.
- Published in:
- Nature Immunology, 2002, v. 3, n. 6, p. 499, doi. 10.1038/ni0602-499
- By:
- Publication type:
- Article
Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8
- By:
- Publication type:
- Article
The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.
- Published in:
- European Journal of Immunology, 2003, v. 33, n. 11, p. 2987, doi. 10.1002/eji.200324238
- By:
- Publication type:
- Article
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1346502
- By:
- Publication type:
- Article